BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™
Stocks in this Quantisnow insightHealth Care
Historical context for BWAY
Across the 29 sessions after earlier BWAY headlines, the stock closed higher 18 times and lower 10 times, with a median move of 3.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | BWAY | SPY |
|---|---|---|---|
| Aug 27, 2026 | BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation | +0.7% | +0.7% |
| Aug 12, 2026 | BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights | +10.8% | +0.3% |
| Jul 29, 2026 | BrainsWay to Report Second Quarter 2026 Financial Results on August 12, 2026 | -8.6% | -1.5% |
| Jul 20, 2026 | BTIG Research initiated coverage on Brainsway with a new price targetand 1 other headline that session | +4.9% | -0.2% |
| Jul 16, 2026 | BrainsWay Announces Minority-Stake Investment in Sound Minds Behavioral | -0.3% | -0.5% |
| Jun 29, 2026 | BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder | +4.8% | +1.6% |
Quantisnow market dataNASDAQ
BWAY
BrainsWay Ltd.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2019
Get push alerts for BWAY
Full BWAY profile on Quantisnow Follow BWAY and get a push notification the moment its next story breaks.